Hikma To Join London's Blue-Chip Index as Shire Exits
19 Décembre 2018 - 8:25PM
Dow Jones News
By Carlo Martuscelli
Hikma Pharmaceuticals PLC (HIK.LN) will joint the FTSE 100
index, replacing Shire PLC (SHP.LN), FTSE Russell said
Wednesday.
FTSE Russell attributed the swap to Shire's takeover by Takeda
Pharmaceutical. London-listed Hikma Pharmaceuticals was founded in
Jordan, and manufactures generic medicines as well as in-licensed
products.
Shares of the company are up 65% in the past 12 months. Demand
of its injectable medicines was recently buoyed by a shortage in
the U.S., and the company reported earnings that beat analyst
expectations in its latest half-year report.
FTSE Russell said that changes to the index will be made
effective from Dec. 24.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
December 19, 2018 14:10 ET (19:10 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Shire (NASDAQ:SHPGY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Shire (NASDAQ:SHPGY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Shire Plc ADS, Each Representing Three Ordinary Shares (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Shire Plc ADS, Each Representing Three Ordinary Shares (MM)